(Q50947118)

25 March 2018

title

Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. (English)

1 reference

25 March 2018

0 references

21

1 reference

25 March 2018

author name string

Na Liu

1

1 reference

25 March 2018

Nian-Yong Chen

2

1 reference

25 March 2018

Rui-Xue Cui

3

1 reference

25 March 2018

Wen-Fei Li

4

1 reference

25 March 2018

Yan Li

5

1 reference

25 March 2018

Rong-Rong Wei

6

1 reference

25 March 2018

Mei-Yin Zhang

7

1 reference

25 March 2018

Ying Sun

8

1 reference

25 March 2018

Bi-Jun Huang

9

1 reference

25 March 2018

Mo Chen

10

1 reference

25 March 2018

Qing-Mei He

11

1 reference

25 March 2018

Ning Jiang

12

1 reference

25 March 2018

Lei Chen

13

1 reference

25 March 2018

William C S Cho

14

1 reference

25 March 2018

Jing-Ping Yun

15

1 reference

25 March 2018

Jing Zeng

16

1 reference

25 March 2018

Li-Zhi Liu

17

1 reference

25 March 2018

Li Li

18

1 reference

25 March 2018

Ying Guo

19

1 reference

25 March 2018

Hui-Yun Wang

20

1 reference

25 March 2018

publication date

3 May 2012

1 reference

25 March 2018

Lancet Oncology Commission

published in

1 reference

25 March 2018

volume

13

1 reference

25 March 2018

issue

6

1 reference

25 March 2018

page(s)

633-641

1 reference

25 March 2018

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970102-X

7 January 2021

Re-evaluation of 6th edition of AJCC staging system for nasopharyngeal carcinoma and proposed improvement based on magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970102-X

7 January 2021

Plasma Epstein-Barr Viral Deoxyribonucleic Acid Quantitation Complements Tumor-Node-Metastasis Staging Prognostication in Nasopharyngeal Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970102-X

7 January 2021

Serum lactate dehydrogenase level is a prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970102-X

7 January 2021

Prospective validation of the prognostic value of elevated serum vascular endothelial growth factor in patients with nasopharyngeal carcinoma: more distant metastases and shorter overall survival after treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970102-X

7 January 2021

MicroRNA expression profiles classify human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970102-X

7 January 2021

MicroRNA signatures in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970102-X

7 January 2021

A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970102-X

7 January 2021

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970102-X

7 January 2021

MicroRNA signature predicts survival and relapse in lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970102-X

7 January 2021

MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970102-X

7 January 2021

MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970102-X

7 January 2021

MicroRNA expression, survival, and response to interferon in liver cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970102-X

7 January 2021

Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970102-X

7 January 2021

MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970102-X

7 January 2021

MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970102-X

7 January 2021

MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970102-X

7 January 2021

Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970102-X

7 January 2021

Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970102-X

7 January 2021

A simple method for RNA isolation from formalin-fixed and paraffin-embedded lymphatic tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970102-X

7 January 2021

A genotyping system capable of simultaneously analyzing >1000 single nucleotide polymorphisms in a haploid genome

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970102-X

7 January 2021

Direct and sensitive miRNA profiling from low-input total RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970102-X

7 January 2021

Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970102-X

7 January 2021

Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970102-X

7 January 2021

The National Cancer Data Base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970102-X

7 January 2021

Lung metastasis alone in nasopharyngeal carcinoma: A relatively favorable prognostic group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970102-X

7 January 2021

Paclitaxel, carboplatin, and gemcitabine in metastatic nasopharyngeal carcinoma: a Phase II trial using a triplet combination.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970102-X

7 January 2021

Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970102-X

7 January 2021

10.1016/S1470-2045(12)70102-X

Identifiers

DOI

1 reference

25 March 2018

1 reference

25 March 2018